OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
The Oxford Society of Ageing and Longevity and Oxford Venture Capital Network are excited to host Sebastian A. Brunemeier on Monday 16th November 18.30 on VC investments in the Longevity Biotech space!
Sebastian, an University of Oxford alumnus, has extensive experience in anti-ageing drug discovery and investing. An advisor to McKinsey & Company and Molecule GmbH, he has co-founded Cambrian Biopharma and Samsara Therapeutics and served as Principal as Apollo Health Ventures. 🚀
Sebastian will be introducing the science of anti-ageing technology, and providing insights into biotech and VC career paths in the longevity industry.
We look forward to seeing you on Monday! Everyone is welcome to register for the free ticket to the online event.
